There was no significant correlation between adverse virological response of patients and their height, weight, tumor size, proportion of sclerosing hepatocellular carcinoma, hemoglobin albumin level, and total bilirubin level (P > 0.05). This evidence concerns the gene ALB and hepatocellular carcinoma.